Michael D. Hankin

Director/Board Member at Nextgen Customer Science LLC

Network origin in Michael D. Hankin first degree

Entity	Entity type	Industry
Nextgen Customer Science LLC 2	Subsidiary		2

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Michael D. Hankin via their personal network

Company	Sector	Related people	Main position
Nextgen Sunroom LLC Nextgen Sunroom LLC Investment ManagersFinance Nextgen Sunroom LLC, a special purpose vehicle formed to make investment in B&Z Homes, Inc.	Investment Managers	Brett Rogers David Churchill	Director/Board Member Director/Board Member
Nextgen Turtlehealth LLC Nextgen Turtlehealth LLC Investment ManagersFinance NextGen Turtlehealth LLC, a special purpose vehicle formed to make investment in Turtle Health Inc.	Investment Managers	Brett Rogers David Churchill	Director/Board Member Director/Board Member
Brown Advisory, Inc. Brown Advisory, Inc. Financial ConglomeratesFinance Brown Advisory, Inc. provides investment and advisory services. It specializes in investment management, strategic advisory, wealth management, and private equity. The firm provides services to individuals, families, institutions, and corporations. The company was founded in 1993 and is headquartered in Baltimore, MD.	Financial Conglomerates	Brett Rogers David Churchill	General Counsel Director of Finance/CFO
NextGen Pluto LLC NextGen Pluto LLC Investment ManagersFinance NextGen Pluto LLC, a special purpose vehicle formed to make investment in Pluto Health Inc.	Investment Managers	Brett Rogers David Churchill	Director/Board Member Director/Board Member
Brown Advisory Private Equity Partners 10 (A) LLLP	Investment Managers	David Churchill	Chief Operating Officer
Brown Advisory Investors 2021 - VGO LLLP	Investment Managers	David Churchill	Chief Operating Officer
PathAI Investors LLC PathAI Investors LLC Investment ManagersFinance Part of Brown Advisory, Inc., PathAI Investors LLC functions as a private equity fund. The company is based in Baltimore, MD. The CEO of the company is Michael D. Hankin.	Investment Managers	David Churchill	Chief Operating Officer
Axiom Direct Investors LLC Axiom Direct Investors LLC Investment ManagersFinance Part of Brown Advisory, Inc., Axiom Direct Investors LLC operates as a private equity fund. The company is based in Baltimore, MD. The CEO of the company is Michael David Hankin.	Investment Managers	David Churchill	Chief Operating Officer
Brown Advisory Investors 2021- AGL 3 LLLP	Investment Managers	David Churchill	Chief Operating Officer
Rochester Christian University	College/University	David Churchill	Masters Business Admin
THE NEW GERMANY FUND, INC.	Investment Trusts/Mutual Funds	Brett Rogers	General Counsel
THE CENTRAL AND EASTERN EUROPE FUND, INC.	Investment Trusts/Mutual Funds	Brett Rogers	Compliance Officer
The Baltimore Efficiency & Economy Foundation, Inc.		Brett Rogers	Director/Board Member
Baltimore Area Council Boy Scouts of America, Inc.		Brett Rogers	Director/Board Member
Outward Bound Baltimore Chesapeake Bay		Brett Rogers	Director/Board Member
Kasina Foundation		Brett Rogers	Director/Board Member
Georgetown University	College/University	Brett Rogers	Undergraduate Degree
University of Maryland	College/University	Brett Rogers	Graduate Degree
Deutsche Asset Management (Japan) Ltd. Deutsche Asset Management (Japan) Ltd. Investment ManagersFinance Deutsche Asset Management (Japan) Ltd. (DeAM-JP) is the Japanese fund management branch of Deutsche Asia Pacific Holdings Pte Ltd., ultimately held by Deutsche Bank AG (NYSE: DB) in Germany. Established in 1985, the firm is located in Tokyo and provides a full range of asset management products and fund management services for individual and institutional investors including public and private pension funds. The Tokyo team manages domestic and overseas public and private pension funds for institutional clients, outsources the management of other funds and distributes a range of mutual funds for retail investors. They are a signatory to the Principles for Responsible Institutional Investors (Japan’s Stewardship Code) which seeks to promote sustainable growth of companies through investment and dialogue.	Investment Managers	Brett Rogers	Compliance Officer
Vita Therapeutics, Inc. Vita Therapeutics, Inc. BiotechnologyHealth Technology Vita Therapeutics, Inc. is a biotechnology company based in Baltimore, MD that develops state-of-the-art cellular therapeutics for the treatment of neuromuscular diseases and cancers. The company uses induced pluripotent stem cell (iPSC) technology to engineer specific cell types designed to replace those that are defective in patients. Vita Therapeutics is progressing its co-leading programs VTA-100 and VTA-300 for the treatment of limb-girdle muscular dystrophy (LGMD) and multiple solid tumors with the goal of filing investigational drug applications with the Food and Drug Administration in 2023. The company is developing these proprietary cellular therapies following a dual development strategy beginning with autologous-derived cells before moving to a universal hypoimmunogenic cell line. Vita Therapeutics was founded in 2019 by Douglas Taylor Falk, M.S. and Peter Andersen, Ph.D. Douglas Taylor Falk has been the CEO since 2019.	Biotechnology	David Churchill	Director/Board Member

Statistics

International

United States	22
Japan	2

Sectoral

Finance	13
Consumer Services	4
Miscellaneous	3
Health Technology	2

Operational

Director/Board Member	15
Chief Operating Officer	6
Corporate Officer/Principal	4
General Counsel	2
Compliance Officer	2

Most connected contacts

Insiders
Brett Rogers	14
David Churchill	14

See all connections